Reme-Flu is Legacy Biotechnologies’ 2-part homeopathic flu remedy designed to help treat symptoms of the flu. Initially, Reme-Flu is expected to be offered on the website www.nutralegacy.com.
In addition, as Reme-Flu nears completion, Legacy Biotechnologies will pursue an agreement with a major marketing company to work directly with both sales and marketing of Reme-Flu in the retail sector. Legacy anticipates that a formal marketing agreement will be reached within the next week.
Martin Schmieg, president and CEO of Nuvilex, said that Reme-Flu will be a great asset to help people of all ages overcome symptoms of the flu. The combination of an internet presence coupled with proven marketing methods will create a strong synergy in helping to quickly build sales and brand awareness of Reme-Flu.
Legacy Biotechnologies is an independent, privately-owned firm specializing in research and development of nutriceutical and cosmeceutical formulations.
Nuvilex is a “Green” products company. Its current products include: Cinnergen, which promotes a healthy glucose metabolism; and Cinnechol, designed to help maintain normal cholesterol levels and support normal cardiovascular function.